BTIG Downgrades St. Jude Medical (STJ) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Needham & Company Raises Price Target on St. Jude Medical (STJ) Following Strong 1Q Results
April 20, 2016 1:14 PM EDTNeedham & Company reiterated a Strong Buy rating on St. Jude Medical (NYSE: STJ), and raised the price target to $75.00 (from $70.00), following the company's 1Q earnings report. STJ reported revenue of $1.448B, ahead of the consensus estimate of $1.436B. EPS was reported at $0.90 compared to consensus of $0.88.... More
